Regulatory assessment
Review the specific material, customer category, intended research scope, and every jurisdiction served.
FRAMEWORK
PMBIO LABSRESEARCH MATERIALSApply for accessQUALITY SYSTEM · PRELIMINARY FRAMEWORK
PMBio Labs is designing a controlled process that separates supplier claims from verified records and prevents a catalog listing from being mistaken for a released material.
SIX CONTROL GATES
These controls are planned operating requirements. They do not claim that PMBio Labs currently holds qualified inventory, laboratory agreements, certifications, or regulatory approval.
Review the specific material, customer category, intended research scope, and every jurisdiction served.
FRAMEWORKVerify legal entity, manufacturing relationship, traceability, specifications, change controls, and quality documentation.
FRAMEWORKQuarantine each received lot, reconcile identifiers, inspect packaging, and preserve chain-of-custody records.
FRAMEWORKEvaluate laboratory identity, sample relationship, methods, raw result context, dates, and specification alignment.
FRAMEWORKA designated reviewer records approval, rejection, or hold status before any availability is displayed.
FRAMEWORKMaintain complaint, deviation, withdrawal, document-revision, and account-monitoring records.
FRAMEWORKEVIDENCE HIERARCHY
A published record should let a qualified customer determine what was tested, who tested it, when it was tested, which method was used, which acceptance criteria applied, and whether the tested sample maps to the offered lot.
Material and lot identifiers agree across records
Testing facility and report date are visible
Methods and reported units are identified
Results are compared with an approved specification
Alterations and superseded versions remain traceable
Release authorization is separate from the laboratory report
WHAT WE WILL NOT CLAIM
No percentage will appear without a verified report mapped to the specific lot.
Documents from unrelated sellers or samples will not represent PMBio inventory.
Testing, accreditation, compliance, and approval will remain distinct statements.
Supplier, format, specification, and material changes require documented review.